Literature DB >> 27884291

Bioinformatic Analysis of Gene Expression for Melanoma Treatment.

Akinori Kawakami1, David E Fisher2.   

Abstract

Bioinformatic analysis of genome-wide gene expression allows us to characterize cells, including melanomas. Gene expression profiles have been generated in various stages of melanomas and analyzed by researchers in unique ways. Lauss et al. compared their melanoma subtypes with those of The Cancer Genome Atlas Network and found consistency between the two studies.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2016        PMID： 27884291      PMCID： PMC5217826          DOI： 10.1016/j.jid.2016.09.011

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


  10 in total

1.  Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance.

Authors:  Willy Hugo; Hubing Shi; Lu Sun; Marco Piva; Chunying Song; Xiangju Kong; Gatien Moriceau; Aayoung Hong; Kimberly B Dahlman; Douglas B Johnson; Jeffrey A Sosman; Antoni Ribas; Roger S Lo
Journal:  Cell       Date:  2015-09-10       Impact factor: 41.582

Review 2.  MITF: master regulator of melanocyte development and melanoma oncogene.

Authors:  Carmit Levy; Mehdi Khaled; David E Fisher
Journal:  Trends Mol Med       Date:  2006-08-08       Impact factor: 11.951

3.  Plasma markers for identifying patients with metastatic melanoma.

Authors:  Harriet M Kluger; Kathleen Hoyt; Antonella Bacchiocchi; Tina Mayer; Jonathan Kirsch; Yuval Kluger; Mario Sznol; Stephan Ariyan; Annette Molinaro; Ruth Halaban
Journal:  Clin Cancer Res       Date:  2011-04-12       Impact factor: 12.531

4.  Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.

Authors:  Eliezer M Van Allen; Diana Miao; Bastian Schilling; Sachet A Shukla; Christian Blank; Lisa Zimmer; Antje Sucker; Uwe Hillen; Marnix H Geukes Foppen; Simone M Goldinger; Jochen Utikal; Jessica C Hassel; Benjamin Weide; Katharina C Kaehler; Carmen Loquai; Peter Mohr; Ralf Gutzmer; Reinhard Dummer; Stacey Gabriel; Catherine J Wu; Dirk Schadendorf; Levi A Garraway
Journal:  Science       Date:  2015-09-10       Impact factor: 47.728

5.  Single-cell gene expression signatures reveal melanoma cell heterogeneity.

Authors:  M Ennen; C Keime; D Kobi; G Mengus; D Lipsker; C Thibault-Carpentier; I Davidson
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

6.  Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome.

Authors:  Göran Jönsson; Christian Busch; Stian Knappskog; Jürgen Geisler; Hrvoje Miletic; Markus Ringnér; Johan R Lillehaug; Ake Borg; Per Eystein Lønning
Journal:  Clin Cancer Res       Date:  2010-05-11       Impact factor: 12.531

7.  Genomic Classification of Cutaneous Melanoma.

Authors: 
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

8.  Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.

Authors:  Itay Tirosh; Benjamin Izar; Sanjay M Prakadan; Marc H Wadsworth; Daniel Treacy; John J Trombetta; Asaf Rotem; Christopher Rodman; Christine Lian; George Murphy; Mohammad Fallahi-Sichani; Ken Dutton-Regester; Jia-Ren Lin; Ofir Cohen; Parin Shah; Diana Lu; Alex S Genshaft; Travis K Hughes; Carly G K Ziegler; Samuel W Kazer; Aleth Gaillard; Kellie E Kolb; Alexandra-Chloé Villani; Cory M Johannessen; Aleksandr Y Andreev; Eliezer M Van Allen; Monica Bertagnolli; Peter K Sorger; Ryan J Sullivan; Keith T Flaherty; Dennie T Frederick; Judit Jané-Valbuena; Charles H Yoon; Orit Rozenblatt-Rosen; Alex K Shalek; Aviv Regev; Levi A Garraway
Journal:  Science       Date:  2016-04-08       Impact factor: 47.728

9.  Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.

Authors:  Willy Hugo; Jesse M Zaretsky; Lu Sun; Chunying Song; Blanca Homet Moreno; Siwen Hu-Lieskovan; Beata Berent-Maoz; Jia Pang; Bartosz Chmielowski; Grace Cherry; Elizabeth Seja; Shirley Lomeli; Xiangju Kong; Mark C Kelley; Jeffrey A Sosman; Douglas B Johnson; Antoni Ribas; Roger S Lo
Journal:  Cell       Date:  2016-03-17       Impact factor: 41.582

10.  Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities.

Authors:  Martin Lauss; Jeremie Nsengimana; Johan Staaf; Julia Newton-Bishop; Göran Jönsson
Journal:  J Invest Dermatol       Date:  2016-06-23       Impact factor: 8.551
  10 in total
  5 in total

1.  PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.

Authors:  Chengyuan Dong; Wenhua Fan; Sheng Fang
Journal:  J Mol Neurosci       Date:  2019-10-15       Impact factor: 3.444

2.  Stepwise-edited, human melanoma models reveal mutations' effect on tumor and microenvironment.

Authors:  Eran Hodis; Elena Torlai Triglia; John Y H Kwon; Tommaso Biancalani; Labib R Zakka; Saurabh Parkar; Jan-Christian Hütter; Lorenzo Buffoni; Toni M Delorey; Devan Phillips; Danielle Dionne; Lan T Nguyen; Denis Schapiro; Zoltan Maliga; Connor A Jacobson; Ayal Hendel; Orit Rozenblatt-Rosen; Martin C Mihm; Levi A Garraway; Aviv Regev
Journal:  Science       Date:  2022-04-29       Impact factor: 63.714

3.  Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.

Authors:  Jana Travnickova; Sonia Wojciechowska; Ava Khamseh; Philippe Gautier; Daniel V Brown; Thomas Lefevre; Alessandro Brombin; Ailith Ewing; Amy Capper; Michaela Spitzer; Ramile Dilshat; Colin A Semple; Marie E Mathers; James A Lister; Eiríkur Steingrimsson; Thierry Voet; Chris P Ponting; E Elizabeth Patton
Journal:  Cancer Res       Date:  2019-10-03       Impact factor: 12.701

Review 4.  Melanoma models for the next generation of therapies.

Authors:  E Elizabeth Patton; Kristen L Mueller; David J Adams; Niroshana Anandasabapathy; Andrew E Aplin; Corine Bertolotto; Marcus Bosenberg; Craig J Ceol; Christin E Burd; Ping Chi; Meenhard Herlyn; Sheri L Holmen; Florian A Karreth; Charles K Kaufman; Shaheen Khan; Sebastian Kobold; Eleonora Leucci; Carmit Levy; David B Lombard; Amanda W Lund; Kerrie L Marie; Jean-Christophe Marine; Richard Marais; Martin McMahon; Carla Daniela Robles-Espinoza; Ze'ev A Ronai; Yardena Samuels; Maria S Soengas; Jessie Villanueva; Ashani T Weeraratna; Richard M White; Iwei Yeh; Jiyue Zhu; Leonard I Zon; Marc S Hurlbert; Glenn Merlino
Journal:  Cancer Cell       Date:  2021-02-04       Impact factor: 31.743

5.  Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.

Authors:  Yajuan Cao; Weikang Zhu; Wanqing Chen; Jianchun Wu; Guozhen Hou; Yan Li
Journal:  Dis Markers       Date:  2019-04-09       Impact factor: 3.434
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.